Početna › Ewingov sarkom › Massachusetts
Kliničke studije za Ewingov sarkom u državi Massachusetts
6 studija za Ewingov sarkom traži sudionike na lokacijama u državi Massachusetts.
Gradovi u državi Massachusetts
Službeni tekst studije (engleski)
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Dana Farber Cancer Institute, Boston
U tijeku regrutacijaFaza 1
Od 2 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07297979Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Dana-Farber Cancer Institute ( Site 1013), Boston
U tijeku regrutacijaFaza 1/2
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103Lurbinectedin in FET-Fused Tumors
- Dana-Farber Cancer Institute, Boston
U tijeku regrutacijaFaza 1/2
Od 10 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
U tijeku regrutacijaFaza 1
Od 16 godina i više · Oba spola · Ažurirano 2. lip 2026. · NCT07197554Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
U tijeku regrutacijaFaza 1/2
Od 12 do 49 godina · Oba spola · Ažurirano 19. velj 2026. · NCT06709495Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.